Alaunos Therapeutics, Inc. Purchase Commitment, Remaining Minimum Amount Committed
Alaunos Therapeutics, Inc. (TCRT) had Purchase Commitment, Remaining Minimum Amount Committed of $19.00 million as of 2013-12-31, per its 10-K filed 2014-03-03.
Discontinued › Notes › Commitment and Contingencies
us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted · last filed 2014-03-03
- 2013-12-31: Purchase Commitment, Remaining Minimum Amount Committed $19.00M.
| Period end | Purchase Commitment, Remaining Minimum Amount Committed |
|---|---|
| 2013-12-31 | $19.00M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |